Imre Repa
Imre Repa has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
- Gábor Bajzik
Institute of Diagnostic Imaging and Radiation Oncology, Health Center, Kaposvár University, Kaposvár, Hungary
1 shared publication - János Strausz
Somogy Megyei Kaposi Mór Oktató Kórház Kaposvár Tallián Gyula u. 20-32. 7400
1 shared publication - Mariann Moizs
1“Moritz Kaposi” General Hospital, Kaposvár, Hungary
1 shared publication - Marianna Rakvács
1“Moritz Kaposi” General Hospital, Kaposvár, Hungary
1 shared publication - Melinda Kovács
Agribiotechnology and Precision Breeding for Food Security National Laboratory, Department of Physiology and Animal Health, Institute of Physiology and Nutrition, Hungarian University of Agriculture and Life Sciences, 7400 Kaposvár, Hungary
1 shared publication - Tamás Donkó
Medicopus Nonprofit Ltd. Kaposvár Hungary
1 shared publication
Latest Publications
- Open Access
- 2 October 2013
- Published by Springer Nature in BMC Public Health
- Vol. 13 (1) , 914
First result of differentiated communication—to smokers and non-smokers—in order to increase the voluntary participation rate in lung screening
Background: Lung cancer is the most common fatal malignacy and also the primary cause of cancer mortality. Participation in lung screening is an important step in diagnosing patient in early stage and it can promise better outcomes. The aim of this preliminary study was to determinate the differences in the participation rate of smokers and non-smokers in lung cancer screening and to determine the communication strategies to increase the participation rate. Methods: In the given period of time (from May to August 2012) out of 1426 people who participated in the lung screening program 1,060 adult volunteers (331 males and 729 females, average age 54.0±9.3 years), completed fully and anonymously author’s questionnaire that contained 28 questions. 25.7% of the respondents were smokers (n=272), 64.6% have never smoked, while 9.7% were former smokers. Results: Mostly former smokers considered lung screening as an effective method for early detection of pulmonary diseases (86.4%). The most important source (41.0%) of information was the general practitioner. The participation rate of non-smokers is higher in lung screening than the ratio of non-smokers in the population. The unclear data suggest that smokers need distinct, concise messages to know why they should regularly undergo lung screening and doctors have a major role in this. Conclusions: We found that smokers significantly more frequently took part in lung screening annually. It is positive that the participation rate of former smokers is higher than non-smokers, it is just a bit lower than the participation rate of smokers—both in annual and biannual participation. The participation rate of non-smokers is higher in lung screening than the rate of non-smokers in the population.
- 2 October 2013
- Published by Springer Nature in BMC Public Health
- Vol. 13 (1) , 914
Open AccessFirst result of differentiated communication—to smokers and non-smokers—in order to increase the voluntary participation rate in lung screening
Background: Lung cancer is the most common fatal malignacy and also the primary cause of cancer mortality. Participation in lung screening is an important step in diagnosing patient in early stage and it can promise better outcomes. The aim of this preliminary study was to determinate the differences in the participation rate of smokers and non-smokers in lung cancer screening and to determine the communication strategies to increase the participation rate. Methods: In the given period of time (from May to August 2012) out of 1426 people who participated in the lung screening program 1,060 adult volunteers (331 males and 729 females, average age 54.0±9.3 years), completed fully and anonymously author’s questionnaire that contained 28 questions. 25.7% of the respondents were smokers (n=272), 64.6% have never smoked, while 9.7% were former smokers. Results: Mostly former smokers considered lung screening as an effective method for early detection of pulmonary diseases (86.4%). The most important source (41.0%) of information was the general practitioner. The participation rate of non-smokers is higher in lung screening than the ratio of non-smokers in the population. The unclear data suggest that smokers need distinct, concise messages to know why they should regularly undergo lung screening and doctors have a major role in this. Conclusions: We found that smokers significantly more frequently took part in lung screening annually. It is positive that the participation rate of former smokers is higher than non-smokers, it is just a bit lower than the participation rate of smokers—both in annual and biannual participation. The participation rate of non-smokers is higher in lung screening than the rate of non-smokers in the population.
- Open Access
- 1 January 2013
- Published by Springer Nature in BMC Veterinary Research
- Vol. 9 (1) , 222
Regeneration of toxigenic Pasteurella multocida induced severe turbinate atrophy in pigs detected by computed tomography
Atrophic rhinitis is a widely prevalent infectious disease of swine caused by Bordetella bronchiseptica and Pasteurella multocida. The course of the disease is considered to be different depending on the principal aetiological agents distinguishing B. bronchiseptica induced non-progressive and toxigenic P. multocida produced progressive forms. In order to compare the pathological events of the two forms of the disease, the development of nasal lesions has longitudinally been studied in pigs infected by either B. bronchiseptica alone or B. bronchiseptica and toxigenic P. multocida together using computed tomography to visualise the nasal structures.
- 1 January 2013
- Published by Springer Nature in BMC Veterinary Research
- Vol. 9 (1) , 222
Open AccessRegeneration of toxigenic Pasteurella multocida induced severe turbinate atrophy in pigs detected by computed tomography
Atrophic rhinitis is a widely prevalent infectious disease of swine caused by Bordetella bronchiseptica and Pasteurella multocida. The course of the disease is considered to be different depending on the principal aetiological agents distinguishing B. bronchiseptica induced non-progressive and toxigenic P. multocida produced progressive forms. In order to compare the pathological events of the two forms of the disease, the development of nasal lesions has longitudinally been studied in pigs infected by either B. bronchiseptica alone or B. bronchiseptica and toxigenic P. multocida together using computed tomography to visualise the nasal structures.